Oncogenic driver mutations in non-small cell lung cancer: Past, present and future

doi:10.5306/wjco.v12.i4.217

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (20588)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

1152

WORD

254

HTML

15336

Figures (1-1)

570

Tables (1-1)

660

Sum=17972

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

457

Download

653

Sum=1110

Publishing Process of This Article

Item

Count

Browse

464

Download

1042

Sum=1506

Apr 24, 2021 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (133)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Apr 24, 2021; 12(4): 217-237
Published online Apr 24, 2021. doi: 10.5306/wjco.v12.i4.217

Full Size Figure Download Figure

Figure 1 Incidence of oncogenic drivers in non-small cell lung cancer. KRAS: Kirsten rat sarcoma; EGFR: Epidermal growth factor receptor; ALK: Anaplastic lymphoma kinase; HER2: Human epidermal growth factor 2; ROS1: c-ROS oncogene 1; NTRK: Neurotrophic receptor tyrosine kinase; RET: Rearranged during transfection; NRG1: Neuregulin-1.

Citation: Chevallier M, Borgeaud M, Addeo A, Friedlaender A. Oncogenic driver mutations in non-small cell lung cancer: Past, present and future . World J Clin Oncol 2021; 12(4): 217-237
URL: https://www.wjgnet.com/2218-4333/full/v12/i4/217.htm
DOI: https://dx.doi.org/10.5306/wjco.v12.i4.217